NYSE: CNMDConmed Corp Stock Ownership - Who owns Conmed?
Insider buying vs selling
Have Conmed Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Richard Glaze | Chief Information Officer | 2025-11-21 | 257 | $41.21 | $10.59kSell |
| Richard Glaze | Chief Information Officer | 2025-11-20 | 118 | $40.63 | $4.79kSell |
| Todd W. Garner | Executive Vice President CFO | 2025-11-06 | 3,500 | $43.00 | $150.50kSell |
| Hollie K. Foust | General Counsel Corp Sec | 2025-11-04 | 1,114 | $45.71 | $50.92kSell |
| Todd W. Garner | Executive Vice President CFO | 2025-10-31 | 2,164 | $44.00 | $95.22kSell |
| Charles Farkas | Director | 2025-09-12 | 897 | $53.51 | $48.00kSell |
| Charles Farkas | Director | 2025-09-12 | 1,103 | $53.54 | $59.05kSell |
| Todd W. Garner | Executive Vice President CFO | 2025-08-07 | 598 | $52.45 | $31.37kSell |
| Charles Farkas | Director | 2025-05-29 | 966 | $57.69 | $55.73kSell |
| Charles Farkas | Director | 2025-05-29 | 1,000 | $55.70 | $55.70kBuy |
CNMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CNMD insiders and whales buy or sell their stock.
CNMD Shareholders
What type of owners hold Conmed Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 15.00% | 4,644,357 | $189.49M | Institution |
| Vanguard Group Inc | 11.66% | 3,610,906 | $147.32M | Institution |
| Earnest Partners LLC | 9.04% | 2,798,703 | $114.19M | Institution |
| Fuller Thaler Asset Management Inc | 5.60% | 1,734,828 | $70.78M | Institution |
| Westwood Holdings Group Inc | 4.29% | 1,329,787 | $54.26M | Institution |
| Bank Of America Corp | 4.20% | 1,301,473 | $53.10M | Institution |
| Dimensional Fund Advisors LP | 4.19% | 1,296,776 | $52.91M | Institution |
| State Street Corp | 4.08% | 1,262,631 | $51.52M | Institution |
| Silvercrest Asset Management Group LLC | 3.47% | 1,073,744 | $43.81M | Institution |
| Capital Research Global Investors | 3.33% | 1,032,733 | $42.14M | Institution |
CNMD vs Medical Device Stocks
Conmed Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.